Back to discover
Disease

Atrioventricular Block

Late-stage therapeutic developmentEmerging research
1
Publications
7
Clinical trials
2020
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q4 2028.

Clinical trials

7 sponsors · 1 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes1
  • Genetic Predisposition to Disease1
Leading journals1
  • Circulation1
Leading researchers8
  • Abiusi E1
  • Ackerman MJ1
  • Adler A1
  • Amenta S1
  • Amin AS1
  • Bikker H1
  • Care M1
  • Feilotter H1
Affiliations (unnormalised)6
  • Columbia University Irving Medical Center1
  • Department of Clinical Genetics (E.A.N.1
  • Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico1
  • Geisinger Genomic Medicine Institute1
  • Heart Center1
  • National Heart and Lung Institute and Medical Research Council London Institute of Medical Sciences1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Impaired impulse conduction from HEART ATRIA to HEART VENTRICLES. AV block can mean delayed or completely blocked impulse conduction.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.